Dec 15, 2022

In this week’s podcast, Neurology Today’s editor-in-chief discusses why MS specialists advocate for rituximab for MS, how food security may relate to cognition, and a novel in utero therapy for Pompe diseasea.

Dec 1, 2022

In this week’s podcast, Neurology Today’s editor-in-chief discusses modifiable risk factors for monogenic stroke, what health care systems need to do to prepare for new Alzheimer’s therapies, and criteria program directors apply in selecting neurology residents.

Nov 17, 2022

In this week’s podcast, Neurology Today’s editor-in-chief discusses data suggesting revascular therapies are safe for patients with stroke and COVID, dementia is associated with increased suicide risk, and the potential of hyperbaric oxygen therapy for children with concussion.

Nov 3, 2022

In this week’s podcast, Neurology Today’s editor-in-chief discusses data suggesting allergic disease is associated with an increased risk of dementia, an increased risk of cancer in children born to women with epilepsy who took high-dose folic acid in pregnancy, and the impact of climate change on people...

Oct 20, 2022

In this week’s podcast, Neurology Today’s editor-in-chief discusses data suggesting vamorolone as an alternative to corticosteroids for Duchenne muscular dystrophy, how an aquaporin protein promotes amyloid clearance, and neurologic events associated with monkeypox virus.